Patent · US Active

Antiviral compositions for the treatment of infections linked to coronaviruses

US11510896B2 · kind B2 · utility

0Cited by

5References

8Claims

0Family size

Assignees

UNIVERSITE CLAUDE BERNAD LYON 1 · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Manuel Rosa-Calatrava · Val-de-Reuil, FR
Olivier Terrier · Val-de-Reuil, FR
Anaïs Proust · L'Essart Mador, FR
Vincent Moules · Belleville, FR

Key dates

Filing date	Oct 20, 2017
Grant date	Nov 29, 2022
Priority date	—
Expiry date	Nov 13, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical or veterinary composition for its use in preventing and/or treating a MERS-CoV (Middle-East Respiratory Syndrome) coronavirus infection, characterised in that it comprises, in a suitable pharmaceutical vehicle, at least one compound chosen from apigenin and berberine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.